Get started
Author

DeQuincy Andrew Lewis

Observed names: D. A. Lewis, D. Lewis, DeQuincy A. Lewis, DeQuincy Lewis, Dequincy Lewis
Observed institutions: Cone Health, Randolph Health, Southeast Clinical Oncology Research Consortium, Indiana University Indianapolis, Indiana University School of Medicine, New York University
OpenAlex ID: A5084737217
Randomized phase II clinical trial of cisplatin/carboplatin and etoposide (CE) alone or in combination with nivolumab as frontline therapy for extensive-stage small cell lung cancer (ES-SCLC): ECOG-ACRIN EA5161.
2020 · Ticiana Leal, Yating Wang, et al. · Journal of Clinical Oncology · 135
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer
2021 · Jeffrey A. Meyerhardt, Qian Shi, et al. · JAMA · 132
PDF
Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)☆
2021 · R. Cohen, Q. Shi, et al. · Annals of Oncology · 112
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes
2024 · Sheri Skerget, Daniel Penaherrera, et al. · Nature Genetics · 93
PDF
Imatinib for the treatment of thymic carcinoma
2008 · J. T. Salter, D. Lewis, et al. · Journal of Clinical Oncology · 65
Positron Emission Tomography Scans in Postchemotherapy Seminoma Patients With Residual Masses: A Retrospective Review From Indiana University Hospital
2006 · DeQuincy A. Lewis, Mark Tann, et al. · Journal of Clinical Oncology · 42
PDF
Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)
2022 · Justin C. Brown, Chao Ma, et al. · Journal of Clinical Oncology · 39
Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702
2022 · Seohyuk Lee, Chao Ma, et al. · Journal of Clinical Oncology · 17
Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance)
2023 · Seohyuk Lee, Chao Ma, et al. · British Journal of Cancer · 16
PDF
Randomized phase III trial of eribulin (E) versus standard weekly paclitaxel (P) as first- or second-line therapy for locally recurrent or metastatic breast cancer (MBC).
2020 · Minetta C. Liu, David W. Hillman, et al. · Journal of Clinical Oncology · 7
Celecoxib in addition to standard adjuvant therapy with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in stage III colon cancer: Results from CALGB/SWOG 80702.
2020 · Jeffrey A. Meyerhardt, Qian Shi, et al. · Journal of Clinical Oncology · 3
Abstract 682: Associations of inflammatory biomarkers with survival among patients with stage III colon cancer (CALGB/SWOG 80702 [Alliance])
2022 · En Cheng, Shi Qian, et al. · Cancer Research · 1
Can patients (pts.) with refractory germ cell tumors (GCT) be cured after progression following high dose chemotherapy (HDCT) with tandem transplant? Results with paclitaxel + gemcitabine
2006 · D. A. Lewis, M. J. Brames, et al. · Journal of Clinical Oncology · 1
Author Correction: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes
2025 · Sheri Skerget, Daniel Penaherrera, et al. · Nature Genetics
PDF
Prognostic value of tumor deposits in stage III colon cancer patients, a post-hoc analysis of CALGB/SWOG 80702 phase III study.
2021 · Romain Cohen, Qian Shi, et al. · Journal of Clinical Oncology
PET scan’s clinical utility in detecting residual disease in postchemotherapy germ cell cancer patients
2005 · D. A. Lewis, M. Tann, et al. · Journal of Clinical Oncology
Works count: 16
Citation count: 662
H-index: 9
I10-index: 9
Year
Topic
Type